Clinical Trial Update: Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial update evaluating different ranibizumab dosing with and without laser therapy for retinal vein occlusion; status completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Vein Occlusion

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Peter A Campochiaro, MD | Conditions: Retinal Vein Occlusion | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-03-15